These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1379398)

  • 21. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.
    McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a conformational epitope on the VP1 G-H Loop of type Asia1 foot-and-mouth disease virus defined by a protective monoclonal antibody.
    Wang H; Zhao L; Li W; Zhou G; Yu L
    Vet Microbiol; 2011 Mar; 148(2-4):189-99. PubMed ID: 20961714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for more than one important, neutralizing site on foot-and-mouth disease virus. Brief report.
    Thomas AA; Woortmeijer RJ; Barteling SJ; Meloen RH
    Arch Virol; 1988; 99(3-4):237-42. PubMed ID: 2453185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.
    Robertson BH; Morgan DO; Moore DM
    Virus Res; 1984 Sep; 1(6):489-500. PubMed ID: 6085200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
    Yang M; Clavijo A; Suarez-Banmann R; Avalo R
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of monoclonal antibodies against FMD virus type Asia-1 and determination of antigenic variations in the field strains.
    Rana SK; Bagchi T
    Vet Immunol Immunopathol; 2008 Apr; 122(3-4):241-9. PubMed ID: 18291535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles.
    McCullough KC; Butcher R
    Arch Virol; 1982; 74(1):1-9. PubMed ID: 6186225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.
    Brown LE; Murray JM; White DO; Jackson DC
    Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic features of foot-and-mouth disease virus serotype Asia1 as revealed by monoclonal antibodies and neutralization-escape mutants.
    Sanyal A; Venkataramanan R; Pattnaik B
    Virus Res; 1997 Aug; 50(2):107-17. PubMed ID: 9282776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing monoclonal antibodies against porcinophilic foot-and-mouth disease virus mapped to antigenic site 2 by utilizing novel mutagenic virus-like particles to detect the antigenic change.
    Lee HW; Deng MC; Pan CH; Chang HW; Cheng IC
    Vet Microbiol; 2018 Aug; 222():124-131. PubMed ID: 30080667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site.
    Feigelstock D; Mateu MG; Piccone ME; De Simone F; Brocchi E; Domingo E; Palma EL
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3307-11. PubMed ID: 1335031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
    Mateu MG; Andreu D; Domingo E
    Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of foot-and-mouth disease virus by monoclonal antibodies.
    Alonso A; Gomes MD; Ramalho AK; Allende R; Barahona H; Söndahl MS; Osorio FA
    Viral Immunol; 1993; 6(3):219-28. PubMed ID: 7507329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic neutralization of rubella virus by monoclonal antibodies to viral haemagglutinin.
    Gerna G; Revello MG; Dovis M; Petruzzelli E; Achilli G; Percivalle E; Torsellini M
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():2007-12. PubMed ID: 2439653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct single-step surface plasmon resonance analysis of interactions between small peptides and immobilized monoclonal antibodies.
    Gomes P; Giralt E; Andreu D
    J Immunol Methods; 2000 Feb; 235(1-2):101-11. PubMed ID: 10675762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen.
    Crevat D; Crance JM; Chevrinais AM; Passagot J; Biziagos E; Somme G; Deloince R
    Arch Virol; 1990; 113(1-2):95-8. PubMed ID: 1696807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of foot-and-mouth disease virus C3 Resende to immunological pressure exerted in vitro by antiviral polyclonal sera.
    Schiappacassi M; Rieder Rojas E; Carrillo E; Campos R
    Virus Res; 1995 Apr; 36(1):77-85. PubMed ID: 7542827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence.
    Barnett PV; Pullen L; Staple RF; Lee LJ; Butcher R; Parkinson D; Doel TR
    J Gen Virol; 1996 May; 77 ( Pt 5)():1011-8. PubMed ID: 8609466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.